tc 99m maa
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT01034514)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
- Imaging
- 99-technetium
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL1201522 ↗
Also known as
- tc 99m maa
- technetium tc 99m maa
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04105283 | Phase 1 | Sep 30, 2019 | BTG, Harvard University |
| NCT01034514 | Early Phase 1 (Phase 1) | Dec 1, 2009 | Stanford University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BTG | For profit | 1 | 0 | 1 | 2019 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2009 |
3 organizations
Page 1 / 1